Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Colorectal Neoplasms 12Rectal Neoplasms 5Pancreatic Neoplasms 4Colonic Neoplasms 4Stomach Neoplasms 2Neoplasm Metastasis 2Urinary Bladder Neoplasms 1Sarcoma 1Resectable MMR-deficient Solid Tumors 1Pancreatic Cancer Metastatic 1Oropharyngeal Neoplasms 1Neoplasms 1Microsatellite Stable Rectal Carcinoma 1Lymphoma 1Gliosarcoma 1Glioma 1Glioblastoma 1Esophageal Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Cancer Metastatic 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Advanced Renal Cell Carcinoma 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1

Interventions

Temozolomide 10Radiotherapy 10Bevacizumab 6Everolimus 5ribociclib 3Radiation 3Panobinostat 3Dasatinib 3Valproic Acid 2TIC10 compound 2Re-Irradiation 2Nivolumab 2Mebendazole 2Irinotecan 2Gemcitabine 2GDC-0084 2Etoposide 2Erlotinib Hydrochloride 2Diphtheria-Tetanus Vaccine 2Cyclophosphamide 2Cilengitide 2Cetuximab 2vandetanib 1tovorafenib 1temsirolimus 1spartalizumab 1sargramostim 1reolysin 1pembrolizumab 1ovex 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Diffuse Intrinsic Pontine Glioma × balstilimab × Clear all
NCT04943848 2026-03-17

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting
36 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡